已收盤 02-06 16:00:00 美东时间
+0.030
+1.53%
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从12美元升至13美元;Guggenheim:维持Praxis Precision Medicine"买入"评级,目标价从540美元升至760美元
2025-12-10 10:33
Barclays analyst Saket Kalia maintains Definitive Healthcare (NASDAQ:DH) with a Underweight and lowers the price target from $3 to $2.75.
2025-12-10 00:33
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
2025-11-11 10:49
Canaccord Genuity analyst David Hynes maintains Definitive Healthcare (NASDAQ:DH) with a Hold and lowers the price target from $5 to $4.
2025-11-11 04:27
Definitive Healthcare Corp. announces that CEO Kevin Coop and CFO Casey Heller will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025, at 9:15 a.m. ET. The presentation will be webcast live on Definitive Healthcare's investor relations website, with a replay available afterward. The company provides healthcare commercial intelligence, empowering clients to identify key markets and opportunities.
2025-09-02 20:05
Earnings Call Insights: Definitive Healthcare Corp. (DH) Q2 2025 Management View CEO Kevin D. Coop reported that "our total revenue was $60.8 million, down 5% year-over-year. This was ahead of expecta...
2025-08-08 17:41